Literature DB >> 12615305

Arenaviruses other than Lassa virus.

Rémi N Charrel1, Xavier de Lamballerie.   

Abstract

The family Arenaviridae includes 23 viral species, of which 5 can cause viral hemorrhagic fevers with a case fatality rate of about 20%. These five viruses are Junin, Machupo, Guanarito, Sabia and Lassa virus, the manipulation of which requires biosafety level 4 facilities. They are included in the Category A Pathogen List established by the Center for Disease Control and Prevention that groups agents with the greatest potential for adverse public health impact and mass casualties whether a situation characterized by a ill-intentioned abuse of natural or engineered arenavirus would be encountered. The aims of this article are to (i) summarize the current situation; (ii) provide information to help anticipating the effects to be expected in such a situation; and to (iii) emphasize the need for fundamental research to allow the development of diagnostic, prevention and therapeutic tools as countermeasures to weaponized arenaviruses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615305     DOI: 10.1016/s0166-3542(02)00202-4

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  79 in total

1.  An antibody recognizing the apical domain of human transferrin receptor 1 efficiently inhibits the entry of all new world hemorrhagic Fever arenaviruses.

Authors:  Gustavo Helguera; Stephanie Jemielity; Jonathan Abraham; Sandra M Cordo; M Guadalupe Martinez; José A Rodríguez; Carlos Bregni; Jinyize J Wang; Michael Farzan; Manuel L Penichet; Nélida A Candurra; Hyeryun Choe
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Polymorphism and signatures of selection in the multimammate rat DQB gene.

Authors:  Joëlle Goüy de Bellocq; Herwig Leirs
Journal:  Immunogenetics       Date:  2009-12-02       Impact factor: 2.846

3.  A Proteomics Survey of Junín Virus Interactions with Human Proteins Reveals Host Factors Required for Arenavirus Replication.

Authors:  Christopher M Ziegler; Philip Eisenhauer; Jamie A Kelly; Loan N Dang; Vedran Beganovic; Emily A Bruce; Benjamin R King; David J Shirley; Marion E Weir; Bryan A Ballif; Jason Botten
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

4.  Junin virus infects mouse cells and induces innate immune responses.

Authors:  Christian D Cuevas; Madakasira Lavanya; Enxiu Wang; Susan R Ross
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

5.  Investigation of clade B New World arenavirus tropism by using chimeric GP1 proteins.

Authors:  Vanessa K Martin; Magali E Droniou-Bonzom; Therese Reignier; Jill E Oldenburg; Alex U Cox; Paula M Cannon
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

6.  Receptor use by the Whitewater Arroyo virus glycoprotein.

Authors:  Therese Reignier; Jill Oldenburg; Meg L Flanagan; Genevieve A Hamilton; Vanessa K Martin; Paula M Cannon
Journal:  Virology       Date:  2007-11-13       Impact factor: 3.616

7.  Molecular Basis for Antibody-Mediated Neutralization of New World Hemorrhagic Fever Mammarenaviruses.

Authors:  Selma Mahmutovic; Lars Clark; Silvana C Levis; Ana M Briggiler; Delia A Enria; Stephen C Harrison; Jonathan Abraham
Journal:  Cell Host Microbe       Date:  2015-12-09       Impact factor: 21.023

8.  Wildlife, exotic pets, and emerging zoonoses.

Authors:  Bruno B Chomel; Albino Belotto; François-Xavier Meslin
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

9.  T cell-dependence of Lassa fever pathogenesis.

Authors:  Lukas Flatz; Toni Rieger; Doron Merkler; Andreas Bergthaler; Tommy Regen; Mariann Schedensack; Lukas Bestmann; Admar Verschoor; Mario Kreutzfeldt; Wolfgang Brück; Uwe-Karsten Hanisch; Stephan Günther; Daniel D Pinschewer
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

10.  Host-species transferrin receptor 1 orthologs are cellular receptors for nonpathogenic new world clade B arenaviruses.

Authors:  Jonathan Abraham; Jo Ann Kwong; César G Albariño; Jiajie G Lu; Sheli R Radoshitzky; Jorge Salazar-Bravo; Michael Farzan; Christina F Spiropoulou; Hyeryun Choe
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.